HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors

December 06, 2023 00:29:56
HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors
COR2ED - Oncology Medical Conversation
HCC: VEGFR-TKIs alone or in combination with immune checkpoint inhibitors

Dec 06 2023 | 00:29:56

/

Show Notes

In this medical education podcast episode, Prof. Peter Galle and Prof. Amit Singal discuss the use of VEGFR-TKIs in the treatment of advanced or unresectable HCC and explain the immunomodulation rationale to combine it with immune checkpoint inhibitor.

Combination approach has been validated recently with the atezolizumab+bevacizumab combination being the new standard of care in 1L setting for advanced HCC patients. In the context of advanced HCC, both experts share their view about the dosing approach with VEGFR-TKI and provide insight to handle the dosing when combining with PD-1 inhibitor.

Both experts reiterate that biomarkers are urgently needed in HCC and summarize the current stratification of patients used to predict the response with VEGFR-TKI monotherapy or in immunotherapy combination. Finally, they emphasize that pre-habilitation of HCC patients is key to make the HCC patient fit for the best available treatment option.

Other Episodes

Episode

December 06, 2023 00:24:55
Episode Cover

Precision oncology: An introduction to molecular testing

This podcast episode provides an introduction to molecular testing in the diagnosis and treatment of cancer.  Prof. David Hong from MD Anderson Cancer Center,...

Listen

Episode

December 06, 2023 00:27:14
Episode Cover

Sarcoma: Updated bone sarcoma guidelines - Clinical implications

In this SARCOMA CONNECT Guidelines Podcast, two SARCOMA CONNECT Experts, Prof. Robert Maki and Prof. Silvia Stacchiotti, discuss recent updates in the ESMO and...

Listen

Episode

December 06, 2023 00:23:31
Episode Cover

Severe PHH. Part 2 - Learnings from clinical practice

In this podcast, Prof. Andra H. James (Professor Emeritus of Obstetrics and Gynecology, Division Maternal Fetal Medicine, Duke University Hospital, Durham, North Carolina, US)...

Listen